Hasenoehrl T, Keilani M, Sedghi Komanadj T, Mickel M, Margreiter M, Marhold M, Crevenna R
Department of Physical Medicine and Rehabilitation, Medical University of Vienna, Waehringer Guertel 18-20, A-1090, Vienna, Austria.
Support Care Cancer. 2015 Aug;23(8):2479-97. doi: 10.1007/s00520-015-2782-x. Epub 2015 May 24.
Physical exercise has been shown to be an effective, safe, and quite inexpensive method to reduce cardiovascular and metabolic risk factors and is currently in the process of establishing its relevance for cancer specific morbidity and mortality. The aim of this systematic review was to focus on specific effects of resistance exercise (RE) in the adjuvant therapy and rehabilitation of prostate cancer patients (PCaPs) receiving or having received androgen deprivation therapy (ADT).
A systematic literature search focusing on relevant and peer-reviewed studies published between 1966 and September 2014, using PubMed, EMBASE, MEDLINE, SCOPUS, and Cochrane Library databases, was conducted.
The majority of studies demonstrated RE as an effective and safe intervention to improve muscular strength and performance, fatigue and quality of life (QoL) in PCaPs, while there is inconclusive evidence concerning cardiovascular performance, body composition, blood lipids, bone mineral density (BMD), and immune response.
Existing evidence leads to the conclusion that RE seems to be a safe intervention in PCaPs with beneficial effects on physical performance capacity and QoL. Nevertheless, further research in this field is urgently needed to increase understanding of exercise interventions in PCaPs.
体育锻炼已被证明是一种有效、安全且成本低廉的方法,可降低心血管和代谢风险因素,目前正在确立其与癌症特定发病率和死亡率的相关性。本系统评价的目的是关注抗阻运动(RE)在接受或已接受雄激素剥夺治疗(ADT)的前列腺癌患者(PCaP)辅助治疗和康复中的特定作用。
使用PubMed、EMBASE、MEDLINE、SCOPUS和Cochrane图书馆数据库,对1966年至2014年9月期间发表的相关同行评审研究进行了系统的文献检索。
大多数研究表明,抗阻运动是一种有效且安全的干预措施,可改善前列腺癌患者的肌肉力量和表现、疲劳及生活质量(QoL),而关于心血管功能、身体成分、血脂、骨矿物质密度(BMD)和免疫反应的证据尚无定论。
现有证据得出结论,抗阻运动似乎是前列腺癌患者的一种安全干预措施,对身体运动能力和生活质量有有益影响。然而,迫切需要在该领域进行进一步研究,以加深对前列腺癌患者运动干预的理解。